Results 201 to 210 of about 426,371 (334)

Precision‐Engineered Silver Single‐Atom Carbon Dot Nanozymes for Theranostic Management of Acute Kidney Injury

Advanced Science, EarlyView.
Mitochondria‐targeted silver single‐atom carbon dot (T‐AgSA‐CDs) nanozymes enable dual SOD/GPx‐like ROS scavenging, real‐time imaging, and therapeutic effects for acute kidney injury (AKI). Atomically dispersed Ag sites synergize with carbon dots to restore renal redox hemostasis, protect mitochondrial function, mitigate inflammation, facilitate post ...
Tianle Tang, Jun Zhang, Yan Wang, Guoping Chen, Kehui Yuan, Yuan He, Chenchen Li, Sumaira Hanif, Yang Yang, Yanli Wang, Pir Muhammad   +10 more
wiley   +1 more source

Deubiquitomic and bioinformatic analyses in cisplatin-treated lung cancer cells. [PDF]

Int J Med Sci
Jin SK, Kim TW, Choi HS, Lee CW, Baek KH.   +4 more
europepmc   +1 more source

LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13

, 2022
Huixin Zhou, Xiaolu Huang, Wenjing Shi, Shihao Xu, Jie Chen, Kate Huang, Yumin Wang   +6 more
openalex   +2 more sources

Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders

Advanced Science, EarlyView.
Summary on the dual potential of cfDNA as biomarkers and therapeutic targets for inflammatory disorders. Figure was created with BioRender.com. ABSTRACT Inflammatory disorders are characterized by immune‐mediated inflammatory cascades that can affect multiple organs.
Jiatong Li, Yumei Wang, Xiaoxi Fan, Miao Xu, Jiawen Li, Wenfei Tan, Jianxiang Zhang, Heran Li   +7 more
wiley   +1 more source

The Influence of Cisplatin on Functionality and Surface Characteristics of Mesenchymal Stromal Cells In Vitro. [PDF]

Int J Mol Sci
von Fournier A, Ehret Kasemo T, Goncalves M, Hackenberg S, Herrmann M, Schmidt M, Stöth M, Meyer T, Gehrke T, Scherzad A.   +9 more
europepmc   +1 more source

Hearing Loss: From Basic to Clinical Science

Advanced Science, EarlyView.
Abstract Hearing loss (HL) affects over 1.5 billion people globally, with genetic factors accounting for ≈50% of congenital cases. Therefore, HL has become a global health issue, driving extensive research from basic science to clinical applications. This Special Collection includes a total of 31 papers, among which 9 are review papers, 21 are research
Renjie Chai, Hai Huang, Jing Zou
wiley   +1 more source

A Case of Pathological Complete Response after "Conversion Surgery" for Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma. [PDF]

Surg Case Rep
Shirakawa Y, Yoh T, Ito T, Ogiso S, Ishii T, Fujimoto M, Haga H, Hatano E.   +7 more
europepmc   +1 more source

Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990) [PDF]

, 1992
John Berg, Mark Weinstein, Scott H. Schelling, William Rand   +3 more
openalex   +1 more source

Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review

Annals of Gastroenterological Surgery, EarlyView.
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley   +1 more source

Comparing three induction regimens for nasopharyngeal carcinoma: a propensity score-matched analysis. [PDF]

Ther Adv Med Oncol
Dai J, Pan Y, Liu Y, Pan Y, Wang D, Liang Y, Wei Y, Chen H, Zhang B, Wu X, Liu B, Kong X, Mo Y, Ruan X, Liao S, Lin X, Huang C, Xu J, Mo F, Jiang W.   +19 more
europepmc   +1 more source